

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Chondrosarcoma: biology, genetics, and epigenetics | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1826/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1826" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Chondrosarcoma: biology, genetics, and epigenetics" />
    
            <meta name="og:title" content="F1000Research Article: Chondrosarcoma: biology, genetics, and epigenetics.">
            <meta name="og:description" content="Read the latest article version by Warren A Chow, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="17424">
            <meta name="article-id" content="15953">
            <meta name="dc.title" content="Chondrosarcoma: biology, genetics, and epigenetics">
            <meta name="dc.description" content="Chondrosarcomas constitute a heterogeneous group of primary bone cancers characterized by hyaline cartilaginous neoplastic tissue. They are the second most common primary bone malignancy. The vast majority of chondrosarcomas are conventional chondrosarcomas, and most conventional chondrosarcomas are low- to intermediate-grade tumors (grade 1 or 2) which have indolent clinical behavior and low metastatic potential. Recurrence augurs a poor prognosis, as conventional chondrosarcomas are both radiation and chemotherapy resistant. Recent discoveries in the biology, genetics, and epigenetics of conventional chondrosarcomas have significantly advanced our understanding of the pathobiology of these tumors and offer insight into potential therapeutic targets.">
            <meta name="dc.subject" content="chondrosarcoma, genetics, epigenetics biology">
            <meta name="dc.creator" content="Chow, Warren A">
            <meta name="dc.date" content="2018/11/20">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.15953.1">
            <meta name="dc.source" content="F1000Research 2018 7:1826">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="chondrosarcoma">
            <meta name="prism.keyword" content="genetics">
            <meta name="prism.keyword" content="epigenetics biology">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/11/20">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1826">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.15953.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1826">
            <meta name="citation_title" content="Chondrosarcoma: biology, genetics, and epigenetics">
            <meta name="citation_abstract" content="Chondrosarcomas constitute a heterogeneous group of primary bone cancers characterized by hyaline cartilaginous neoplastic tissue. They are the second most common primary bone malignancy. The vast majority of chondrosarcomas are conventional chondrosarcomas, and most conventional chondrosarcomas are low- to intermediate-grade tumors (grade 1 or 2) which have indolent clinical behavior and low metastatic potential. Recurrence augurs a poor prognosis, as conventional chondrosarcomas are both radiation and chemotherapy resistant. Recent discoveries in the biology, genetics, and epigenetics of conventional chondrosarcomas have significantly advanced our understanding of the pathobiology of these tumors and offer insight into potential therapeutic targets.">
            <meta name="citation_description" content="Chondrosarcomas constitute a heterogeneous group of primary bone cancers characterized by hyaline cartilaginous neoplastic tissue. They are the second most common primary bone malignancy. The vast majority of chondrosarcomas are conventional chondrosarcomas, and most conventional chondrosarcomas are low- to intermediate-grade tumors (grade 1 or 2) which have indolent clinical behavior and low metastatic potential. Recurrence augurs a poor prognosis, as conventional chondrosarcomas are both radiation and chemotherapy resistant. Recent discoveries in the biology, genetics, and epigenetics of conventional chondrosarcomas have significantly advanced our understanding of the pathobiology of these tumors and offer insight into potential therapeutic targets.">
            <meta name="citation_keywords" content="chondrosarcoma, genetics, epigenetics biology">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Warren A Chow">
            <meta name="citation_author_institution" content="Department of Medical Oncology &amp; Therapeutics Research, City of Hope, 1500 E. Duarte Rd, Duarte, CA, 91010, USA">
            <meta name="citation_publication_date" content="2018/11/20">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1826">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.15953.1">
            <meta name="citation_firstpage" content="1826">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1826/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1826.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=17424 /> <input type=hidden id=articleId name=articleId value=15953 /> <input type=hidden id=xmlUrl value="/articles/7-1826/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1826-v1.xml"> <input type=hidden id=article_uuid value=c8cf8801-6c95-417a-b343-e6003e1bf932 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Chondrosarcoma: biology, genetics, and epigenetics"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.15953.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.15953.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1826"
  },
  "headline": "Chondrosarcoma: biology, genetics, and epigenetics",
  "datePublished": "2018-11-20T16:45:24",
  "dateModified": "2018-11-20T16:45:24",
  "author": [
    {
      "@type": "Person",
      "name": "Warren A Chow"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Chondrosarcomas constitute a heterogeneous group of primary bone cancers characterized by hyaline cartilaginous neoplastic tissue. They are the second most common primary bone malignancy. The vast majority of chondrosarcomas are conventional chondrosarcomas, and most conventional chondrosarcomas are low- to intermediate-grade tumors (grade 1 or 2) which have indolent clinical behavior and low metastatic potential. Recurrence augurs a poor prognosis, as conventional chondrosarcomas are both radiation and chemotherapy resistant. Recent discoveries in the biology, genetics, and epigenetics of conventional chondrosarcomas have significantly advanced our understanding of the pathobiology of these tumors and offer insight into potential therapeutic targets."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1826",
            "name": "Chondrosarcoma: biology, genetics, and epigenetics"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Chondrosarcoma: biology, genetics, and epigenetics </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=17424 data-id=15953 data-downloads="" data-views="" data-scholar="10.12688/f1000research.15953.1" data-recommended="" data-doi="10.12688/f1000research.15953.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1826/v1/pdf?article_uuid=c8cf8801-6c95-417a-b343-e6003e1bf932" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-15953-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-15953-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-15953-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Chow WA. Chondrosarcoma: biology, genetics, and epigenetics [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1826 (<a class=new-orange href="https://doi.org/10.12688/f1000research.15953.1" target=_blank>https://doi.org/10.12688/f1000research.15953.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-15953-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=15953 id=track-article-signin-15953 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/15953?target=/articles/7-1826">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17424 /> <input name=articleId type=hidden value=15953 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Chondrosarcoma: biology, genetics, and epigenetics</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:wchow@coh.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Warren A Chow</span></a><a href="https://orcid.org/0000-0003-0889-5841" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-0889-5841</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:wchow@coh.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Warren A Chow</span></a><a href="http://orcid.org/0000-0003-0889-5841" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-0889-5841</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 20 Nov 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.15953.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Medical Oncology &amp; Therapeutics Research, City of Hope, 1500 E. Duarte Rd, Duarte, CA, 91010, USA<br/> <p> <div class=margin-bottom> Warren A Chow <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Resources, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=41732-40644></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=18252-40642></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Chondrosarcomas constitute a heterogeneous group of primary bone cancers characterized by hyaline cartilaginous neoplastic tissue. They are the second most common primary bone malignancy. The vast majority of chondrosarcomas are conventional chondrosarcomas, and most conventional chondrosarcomas are low- to intermediate-grade tumors (grade 1 or 2) which have indolent clinical behavior and low metastatic potential. Recurrence augurs a poor prognosis, as conventional chondrosarcomas are both radiation and chemotherapy resistant. Recent discoveries in the biology, genetics, and epigenetics of conventional chondrosarcomas have significantly advanced our understanding of the pathobiology of these tumors and offer insight into potential therapeutic targets. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> chondrosarcoma, genetics, epigenetics biology </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Warren A Chow (<a href="mailto:wchow@coh.org">wchow@coh.org</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Warren A Chow </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Chow WA. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Chow WA. Chondrosarcoma: biology, genetics, and epigenetics [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1826 (<a href="https://doi.org/10.12688/f1000research.15953.1" target=_blank>https://doi.org/10.12688/f1000research.15953.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 20 Nov 2018, <b>7</b>(F1000 Faculty Rev):1826 (<a href="https://doi.org/10.12688/f1000research.15953.1" target=_blank>https://doi.org/10.12688/f1000research.15953.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 20 Nov 2018, <b>7</b>(F1000 Faculty Rev):1826 (<a href="https://doi.org/10.12688/f1000research.15953.1" target=_blank>https://doi.org/10.12688/f1000research.15953.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d39988e134>Introduction</h2><p class="" id=d39988e137>Chondrosarcoma (CS) is the collective term for a group of heterogeneous, generally slow-growing, primary malignant tumors of bone characterized by the formation of hyaline cartilaginous neoplastic tissue. They primarily affect adults and are the second most common primary solid tumor of bone after osteogenic sarcoma<sup><a href="#ref-1">1</a></sup>. CS account for approximately 3 new cases per 10<sup>6</sup> population per year<sup><a href="#ref-2">2</a></sup>. The prognosis for the majority of patients with CS is favorable and correlates with histologic grade and adequate surgical margins<sup><a href="#ref-3">3</a></sup>. Development of pulmonary metastatic disease is typically an ominous sign, however, owing to chemotherapy and radiation resistance. This is a result of its underlying phenotype: poor vascularization, slow division rate, and hyaline cartilaginous matrix prohibiting access to the cells. Recent research on the biology, genetics, and epigenetics of CS will be reviewed.</p><p class="" id=d39988e155>More than 90% of CS are conventional CS<sup><a href="#ref-3">3</a></sup>. Approximately 90% of these are low- to intermediate-grade (grade 1–2) and behave indolently and rarely metastasize<sup><a href="#ref-3">3</a></sup>. Only 5–10% of conventional CS are grade 3 and have high metastatic potential<sup><a href="#ref-4">4</a></sup>. CS that arise unassociated with a pre-existing lesion are called primary CS, and they are known as secondary if they develop from a pre-existing benign cartilage tumor such as an enchondroma or osteochondroma. They are further classified as central when they arise within the medullary cavity and peripheral when they arise from the bone surface, generally from the cartilage cap of an exostosis. Primary CS are nearly always central; secondary CS can be central or peripheral<sup><a href="#ref-5">5</a></sup>. Although CS are considered both chemotherapy and radiation resistant, there are rare case reports of responses to conventional chemotherapeutic agents, including gemcitabine<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>.</p><p class="" id=d39988e181>Variant CS subtypes are significantly less common<sup><a href="#ref-1">1</a>,<a href="#ref-4">4</a>,<a href="#ref-5">5</a></sup>. Dedifferentiated CS develop when low-grade conventional CS transform into a high-grade sarcoma, most frequently exhibiting features of osteosarcoma, fibrosarcoma, or undifferentiated pleomorphic sarcoma (UPS). Mesenchymal CS (MCS) is a highly malignant tumor exhibiting a bimorphic histologic pattern, with a highly undifferentiated small round cell component admixed with islands of well-differentiated cartilage. The <i>HEY1–NCOA2</i> fusion has been identified in MCS<sup><a href="#ref-8">8</a></sup>. Delayed recurrences after more than 20 years are not uncommon<sup><a href="#ref-9">9</a></sup>. Clear cell CS is a low-grade malignant tumor that most commonly involves the epiphyses of the long bones; the tumor cells are clear because their cytoplasm contains large amounts of glycogen<sup><a href="#ref-10">10</a></sup>. Extraskeletal myxoid CS is also a slow-growing soft-tissue tumor containing prominent myxoid degeneration and characterized by a prolonged clinical course despite high rates of local recurrence and metastases<sup><a href="#ref-11">11</a></sup>. It is characterized by t(9;22)(q22;q12), fusing <i>EWSR1</i> to <i>NRA3</i> (genes formerly termed <i>CHN</i>, <i>TEC</i>, or <i>NOR1</i>)<sup><a href="#ref-12">12</a></sup>. Other translocation partners to <i>NRA3</i> include <i>TAF15</i> and <i>TCF12</i><sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a></sup>. Because of the rarity of these variant CS, the remainder of this review will be dedicated to the more-prevalent conventional CS subtype.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39988e252>Normal bone formation</h2><p class="" id=d39988e255>Normal bone formation is a result of the production of hyaline cartilage matrix produced by chondrocytes, followed by ossification of the matrix by osteoblasts. First, mesenchymal stem cells differentiate at the epiphyseal growth plate into resting chondrocytes, which then migrate into a proliferative zone, where they multiply and increase the cellularity of the matrix (<a href="#f1">Figure 1</a>). These proliferative cells then leave the epiphyseal plate before undergoing a hypertrophic phase, whereby they mature into large clear cells. Eventually, the cells undergo apoptosis, leaving behind the characteristic hypocellular hyaline cartilage matrix. Osteoblasts then migrate into this matrix and initiate ossification<sup><a href="#ref-15">15</a></sup>.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/17424/bd851f01-7fa2-4099-a89c-7940696d6770_figure1.gif"><img alt="bd851f01-7fa2-4099-a89c-7940696d6770_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/17424/bd851f01-7fa2-4099-a89c-7940696d6770_figure1.gif"></a><div class=caption><h3>Figure 1. The IHH/PTHrP signaling pathway.</h3><p id=d39988e275>Indian hedgehog (IHH) is secreted by prehypertrophic and hypertrophic chondrocytes. IHH stimulates the secretion of parathyroid hormone-related protein (PTHrP) in the periarticular growth plate by periarticular proliferating chondrocytes (long solid arrow). IHH also induces the division of columnar proliferating chondrocytes in a positive feedback loop (short solid arrow). PTHrP then acts on the columnar proliferating chondrocytes to inhibit their hypertrophic differentiation and maintain them in a proliferative state (short solid T-bar). PTHrP also inhibits IHH secretion via a negative feedback loop, eventually shutting down the proliferative signal (long solid T-bar). IHH also acts on perichondrial cells to induce mature osteoblasts, which form a bone collar (blue arrows). Adapted from Chung UI, Schipani E, McMahon AP, Kronenberg HM. <b>Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development</b>. <i>J Clin Invest.</i> 2001;<b>107</b>:295-304.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39988e294>(Benign) cartilaginous neoplasms</h2><p class="" id=d39988e297>Osteochondromas are benign cartilaginous neoplasms consisting of a cartilage-capped bony projection on the surface of the bone, containing a marrow cavity continuous with the underlying bone<sup><a href="#ref-16">16</a></sup>. They are one of the most common benign bone tumors. Approximately 15% of cases present with multiple lesions characteristic of the autosomal dominant multiple osteochondroma (MO) genetic disorder. The risk of malignant transformation to secondary peripheral CS is estimated at 1% for sporadic osteochondroma and less than 5% for MO<sup><a href="#ref-17">17</a></sup>. Biallelic inactivation of the exostosin glycosyltransferase<i></i> (<i>EXT1</i> or <i>EXT2</i>) genes is observed in the majority of both sporadic and hereditary osteochondroma cases<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>. The EXT proteins are required for the polymerization of heparan sulfate (HS) chains forming the hyaline cartilage.</p><p class="" id=d39988e324>Interestingly, the cells of peripheral CS are predominantly EXT1 positive<sup><a href="#ref-20">20</a></sup>, unlike the EXT1-negative cells within osteochondromas. Hence, EXT loss is likely an early event. The EXT-negative cells in osteochondroma create an extracellular mutation-promoting environment, whereupon neighboring EXT-positive cells acquire late-stage mutations that cause malignant transformation into CS.</p><p class="" id=d39988e331>Enchondromas are benign cartilaginous neoplasms that arise within the medullary cavity of bone, in contrast to osteochondromas, which arise on the surface. Histologically, they closely resemble grade 1 CS, and radiographic correlation for benign features is necessary for diagnosis. Mutations in the isocitrate dehydrogenase (<i>IDH</i>) <i>1</i> and <i>2</i> genes are present in 85% of hereditary enchondromatosis-associated disorders, Ollier disease (enchondromatosis only), and Maffuci syndrome (enchondromatosis and hemangiomas) and 50% of solitary enchondromas<sup><a href="#ref-21">21</a></sup>. The risk of transformation into secondary central CS in patients affected by enchondromatosis is approximately 40% for Ollier disease and up to 53% in Maffuci syndrome<sup><a href="#ref-22">22</a></sup>.</p><p class="" id=d39988e351><i>IDH</i> mutations are present in 52–59% of central CS and 57% of dedifferentiated CS<sup><a href="#ref-23">23</a></sup>. The presence of <i>IDH</i> mutations in benign enchondromas and malignant CS supports the notion that <i>IDH</i> mutations are an early event, and these cartilaginous neoplasms represent a spectrum of malignant potential. <i>IDH</i> mutations are found in gliomas, acute myeloid leukemia (AML), and cholangiocarcinomas<sup><a href="#ref-24">24</a></sup>. IDH is an enzyme involved in the tricarboxylic acid cycle (Krebs cycle), where it normally converts isocitrate to α-ketoglutarate (α-KG). Mutant <i>IDH</i> (m<i>IDH</i>) loses the ability to convert isocitrate to α-KG and gains a new function that leads to the accumulation of δ-2-hydroxyglutarate (D2HG). D2HG is considered an oncometabolite owing to its inhibition of α-KG-dependent dioxygenases involved in DNA and histone demethylation, which leads to a hypermethylated state of DNA and histones<sup><a href="#ref-25">25</a></sup>. However, clearly <i>IDH</i> mutations alone are insufficient for malignant transformation similar to EXT loss.</p><p class="" id=d39988e388>Inhibition of oncogenic m<i>IDH1/2</i> represents an opportunity for therapeutic intervention. Many of these inhibitors have been, or are being, evaluated in clinical trials for patients with AML or solid tumors, including CS<sup><a href="#ref-26">26</a></sup>. Agios Pharmaceuticals have the furthest clinically developed compounds. Ivosidenib (AG-120), an IDH1 inhibitor, and enasidenib (AG-221), an IDH2 inhibitor, are FDA approved in the U.S. for refractory AML with <i>mIDH1</i> and <i>mIDH2</i>, respectively. AG-881, a pan-mIDH1/2 inhibitor, is in early phase clinical testing. Likewise, IDH305 (Novartis), FT-2102 (Forma Therapeutics), and BAY1436032 (Bayer) are in early phase clinical testing. m<i>IDH</i> inhibition is a promising therapeutic approach in advanced CS.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39988e410><i>COL2A1</i>&nbsp;</h2><p class="" id=d39988e415>The Cancer Genome Project (Wellcome Trust Sanger Institute, Cambridge, UK) performed the first large-scale whole-exome sequencing of 49 cases of 30 central, 4 peripheral, and 14 dedifferentiated CS along with matching normal tissue<sup><a href="#ref-27">27</a></sup>. In addition to confirming <i>IDH1/2</i> mutations in 59% of the cases, the investigators identified hypermutability of the major cartilage collagen gene <i>COL2A1</i>, with insertions, deletions, and rearrangements identified in 37% of cases. <i>COL2A1</i> encodes the α-chain of type II collagen fibers, the major collagen constituent of articular cartilage. Disruption of the collagen maturation process through production of aberrant pro-collagen α-chain is the likely result. The investigators hypothesized that <i>COL2A1</i> mutations might bring about fundamental perturbation of matrix deposition and signaling that contributes to oncogenesis through abrogation of normal differentiation programs in CS.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39988e437>Hedgehog pathway</h2><p class="" id=d39988e440>The Hedgehog (HH) pathway is vital for normal embryogenesis and plays essential roles in the maintenance, renewal, and regeneration of adult tissue. The mammalian HH ligand Indian (IHH) initiates signaling through binding to the canonical membrane receptor Patched (PTCH1). IHH binding to PTCH1 results in derepression of Smoothened (SMO) and results in SMO accumulation. SMO mediates activation of the GLI transcription factor to initiate a series of cellular responses that range from survival and proliferation to cell fate specification and differentiation<sup><a href="#ref-28">28</a></sup>.</p><p class="" id=d39988e447>Chondrogenesis is regulated by the IHH/parathyroid hormone-related protein (PTHrP) pathway. IHH, the product of proliferating chondrocytes, self-induces chondrocyte cell division as well as the secretion of PTHrP by perichondrial chondrocytes. PTHrP inhibits chondrocyte differentiation and maintains them in a proliferative state. PTHrP also negatively regulates IHH in a negative feedback loop to allow the chondrocytes to differentiate in a controlled manner (<a href="#f1">Figure 1</a>).</p><p class="" id=d39988e453>Given the important role for HH signaling in chondrogenesis, therapeutic targeting of this pathway in CS has been investigated. The SMO inhibitors HPI-4 and IPI-926 have been reported to inhibit CS cell line growth <i>in vitro</i> and <i>in vivo</i> in a xenograft model<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>. Despite the promising preclinical reports, a randomized, double-blind, placebo-controlled phase 2 trial of IPI-926 (saridegib) in patients with advanced CS was negative<sup><a href="#ref-31">31</a></sup>. Furthermore, a separate single-arm phase 2 trial of the SMO inhibitor vismodegib (GDC-0049) was similarly discouraging, as it did not meet the primary endpoint of 6-month clinical benefit<sup><a href="#ref-32">32</a></sup>. Despite these disappointing results, new and more-potent HH pathway inhibitors are in development<sup><a href="#ref-28">28</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39988e486>Tumor suppressor pathways</h2><p class="" id=d39988e489>Perturbations to tumor suppressor pathways are common in CS. Alterations in the retinoblastoma (Rb) tumor pathway were observed in 33% (whole-exome sequencing) to 96% (immunohistochemistry [IHC]) of cases of conventional and dedifferentiated CS<sup><a href="#ref-27">27</a>,<a href="#ref-33">33</a></sup>. Rb binds to and inhibits the E2F transcription factor to restrict G1 to S phase of the cell cycle division. This may occur through loss of heterozygosity (LOH) of Rb in grade 3 CS and dedifferentiated CS<sup><a href="#ref-34">34</a></sup>, increased expression of cyclin-dependent kinase 4 (CDK4) or cyclin D1, or reduced expression of CDKN2A/p16<sup><a href="#ref-33">33</a></sup>. There are multiple CDK4/6 inhibitors (palbociclib, ribociclib, and abemaciclib) approved for the treatment of hormone receptor-positive breast cancer in combination with hormone therapy. CDK4/6 inhibitors are a rational approach to test in advanced CS.</p><p class="" id=d39988e507><i>TP53</i> is the most commonly mutated gene in human tumors. Likewise, alterations in the <i>TP53</i> gene occur in 20–50% of conventional and dedifferentiated CS<sup><a href="#ref-27">27</a>,<a href="#ref-35">35</a></sup>. p53 protein inactivation may also occur by binding to mouse double minute 2 homolog (MDM2). Overexpression of MDM2 by IHC was reported in 33% of high-grade CS, and MDM2 mRNA expression correlated with increasing histological grade<sup><a href="#ref-33">33</a></sup>. These results suggest that strategies to block the p53–MDM2 interaction with small molecule antagonists like RG7112 (F Hoffman-La Roche) to restore p53 function may be a therapeutic avenue to explore in this subset of CS similar to its investigation in well-differentiated liposarcomas<sup><a href="#ref-36">36</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39988e533>PI3K–Akt–mTOR pathway</h2><p class="" id=d39988e536>Membrane receptor tyrosine kinase (RTK) activation triggers activation of the lipid kinase PI3K, which generates PIP3. The serine-threonine kinase Akt is activated in part by binding of PIP3. Akt regulates multiple biological processes including cell survival, proliferation, growth, and glycogen metabolism. Phosphatase and tensin homolog (PTEN) is a lipid phosphatase that catalyzes the dephosphorylation of PIP3 to negatively regulate Akt. Loss of PTEN function has been implicated in many human cancers; however, <i>PTEN</i> mutations are rare in CS despite evidence of active Akt signaling<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>.</p><p class="" id=d39988e549>The mammalian target of rapamycin (mTOR) kinase regulates cell cycle progression, cellular proliferation and growth, autophagy, and angiogenesis by integrating energy and nutrient status and PI3K/AKT signaling<sup><a href="#ref-39">39</a></sup>. S6 phosphorylation, a surrogate of PI3K/mTOR activation, was observed in 73/106 (69%) of conventional and 11/25 (44%) of dedifferentiated CS clinical samples<sup><a href="#ref-38">38</a></sup>. Treatment with BEZ235, a dual PI3K/mTOR inhibitor, inhibited the growth of all CS cell lines tested and G1 arrest without induction of apoptosis<sup><a href="#ref-38">38</a></sup>. A combination of the mTOR inhibitor sirolimus and low-dose daily cyclophosphamide in 10 patients with advanced conventional CS resulted in one (10%) objective response, and six (60%) patients had stabilization of disease for at least 6 months<sup><a href="#ref-40">40</a></sup>. Investigation of PI3K–Akt–mTOR pathway inhibition in CS should continue.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39988e571>microRNA</h2><p class="" id=d39988e574>MicroRNAs (miRNAs) are 18–24 nucleotide length, small noncoding RNAs that regulate eukaryotic gene expression at the post-transcriptional level by binding to 6–8 nucleotides at the 3’ untranslated region (3’ UTR) of their target mRNAs. The short miRNA–mRNA binding site permits each miRNA to target multiple mRNAs. There are nearly 600 miRNAs in the human genome, which target approximately 60% of all human genes<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>.</p><p class="" id=d39988e584>miRNAs are involved in normal chondrogenesis. For example, miR-140 negatively regulates histone deacetylase 4 (HDAC4) in non-hypertrophic chondrocytes<sup><a href="#ref-43">43</a></sup>. HDAC4 regulates the chondrocyte hypertrophic phase by inhibiting runt-related transcription factor 2 (RUNX2). When miR-140 binds HDAC4, RUNX2 inhibition is removed, and chondrocyte hypertrophy is enhanced prior to entering the apoptotic phase before ossification. Not surprisingly, miRNAs are also intimately involved in CS oncogenesis. miR-100 is a tumor suppressor that targets and inhibits mTOR and is downregulated in CS<sup><a href="#ref-44">44</a></sup>. Forced expression of miR-100 sensitizes CS cell lines to cisplatin. Similarly, miR-30a decreases tumor proliferation, migration, and invasion through targeting of oncogenic SRY-related HMG box 4 (SOX4)<sup><a href="#ref-45">45</a></sup>. In contrast, miR-181a is considered a CS oncogene, as it is overexpressed in high-grade CS, is upregulated by hypoxia, and increases vascular endothelial growth factor (VEGF) expression by targeting regulator of G-protein signaling 16 (RGS16), a negative regulator of CXC chemokine receptor 4 (CXCR4) signaling<sup><a href="#ref-46">46</a></sup>. These studies demonstrate the complex interplay of miRNA in CS oncogenesis.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39988e606>Epigenetics</h2><p class="" id=d39988e609>Post-transcriptional gene regulation is caused by DNA methylation and histone modification. In CS, the promoter of the tumor suppressor gene <i>P16<sup>INK4a</sup></i> is hypermethylated<sup><a href="#ref-47">47</a></sup>. Similarly, hypermethylation of the promoter region of the tumor suppressor <i>RUNX3</i> transcription factor leads to reduced gene expression, increased proliferation, and reduced apoptosis in CS cells <i>in vitro</i><sup><a href="#ref-48">48</a></sup>. Expression of RUNX3 correlates with improved CS clinical outcomes, further underlying the importance of DNA methylation in CS<sup><a href="#ref-48">48</a></sup>. Naturally, the postulated mechanism is mutant <i>IDH</i>-induced accumulation of D2HG leading to inhibition of the demethylase TET methylcytosine dioxygenase proteins. However, a recent report suggests alternative mechanism(s) are responsible<sup><a href="#ref-49">49</a></sup>. This analysis of 92 central and 45 peripheral CS tumors showed that although the CS were strongly positive for the H3K4me3, H3K9me3, and H3K27me3 histone modifications, neither these modifications nor the variable levels of 5-hydroxymethylcytosine and 5-methylcytosine correlated with <i>IDH1/2</i> mutation status.</p><p class="" id=d39988e645>Inhibition of DNA methyltransferase in the H-EMC-SS CS cell line with decitabine restored expression of the hypermethylated gene encoding HS 3-O-sulfotransferase 2 (HS3ST2), an enzyme essential for HS biosynthesis<sup><a href="#ref-50">50</a></sup>. This resulted in reduced proliferation, invasion, and adhesion. However, in the Swarm rat CS (SRC) model, global demethylation induced by decitabine led to CS progression <i>in vitro</i> and <i>in vivo</i><sup><a href="#ref-51">51</a></sup>. These conflicting results indicate significantly more research is needed before therapeutic targeting of epigenetic modification can proceed.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39988e664>Integrins</h2><p class="" id=d39988e667>Integrins are a family of heterodimeric transmembrane adhesion receptors which mediate cell–cell and cell–extracellular matrix (ECM) interactions. To date, 24 distinct integrin heterodimers have been identified, generated from various combinations of 18 α- and 8 β-subunits. Integrin signaling interacts between both growth factor and chemokine signaling. As a result, integrins play critical roles in cancer cell migration, invasion, and metastasis through their two principal functions: attachment of the cell to the ECM and signal transduction from the ECM to the cell<sup><a href="#ref-52">52</a></sup>.</p><p class="" id=d39988e674>CS consists of abundant ECM with few dividing cells and poor vascularity<sup><a href="#ref-53">53</a></sup>. This may account for its primary resistance to both chemotherapy and radiation therapy. In CS, growth factors and chemokines/cytokines control the expression of specific integrins to promote cell migration. For example, insulin-like growth factor-1 (IGF-1) increases the migration of CS cells by increasing αvβ1 integrin expression<sup><a href="#ref-54">54</a></sup>, and CXCL12/SDF-1 chemokine, which is normally secreted by the lung epithelium, enhances the invasiveness of CS cells by increasing αvβ3 integrin expression through the CXCR4/ERK/NF-κB pathway<sup><a href="#ref-55">55</a></sup>. This may account for the tropism for lung metastases. Despite preclinical rationale for targeting integrin signaling, late-phase clinical trials of a synthetic peptide integrin antagonist (cilengitide) with radiotherapy in glioblastoma and an anti-αv-integrin antibody (abituzumab) in combination with chemotherapy and cetuximab (anti-EGFR antibody) in colorectal cancer have reported disappointing results<sup><a href="#ref-56">56</a>,<a href="#ref-57">57</a></sup>. These results highlight the complexity of targeting diverse integrin family members with significant redundancy.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39988e699>Angiogenesis</h2><p class="" id=d39988e702>Expression of the proangiogenic ligand VEGF is dependent upon hypoxia-inducible factor-1α (HIF-1α), which is upregulated under hypoxic conditions<sup><a href="#ref-58">58</a></sup>. Both normal and malignant chondrocytes induce HIF-1α expression during hypoxia, and HIF-1α expression directly correlates with reduced disease-free survival<sup><a href="#ref-59">59</a></sup>. Further, CS vascularity increases with increased histologic grade<sup><a href="#ref-60">60</a></sup>. Accordingly, our phase 2 study of pazopanib, a multi-targeted receptor tyrosine kinase inhibitor (including VEGF-R) (NCT01330966), in patients with unresectable or metastatic CS has completed accrual and is currently undergoing analysis for safety and efficacy. Pending these results, inhibition of angiogenesis may be another therapeutic avenue for CS.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39988e721>Immunotherapy</h2><p class="" id=d39988e724>Immune checkpoint blockade with anti-PD1 (programmed death 1) and anti-PD-L1 (PD-ligand 1) antibodies has transformed solid tumor oncology. Positive clinical outcomes have generally correlated with tumor mutational burden (TMB) and PD-L1 expression<sup><a href="#ref-61">61</a></sup>. In contrast, sarcomas generally have quiescent genomes and low TMB; CS were in the lowest decile in an analysis of TMB in over 100,000 cancer genomes in 167 distinct cancer types<sup><a href="#ref-62">62</a></sup>. In addition, PD-L1 expression in sarcomas is low<sup><a href="#ref-63">63</a></sup>. In a phase 2 trial of the anti-PD-1 antibody pembrolizumab, conducted by the Sarcoma Alliance for Research through Collaboration (SARC), 1 out of 5 (20%) subjects with dedifferentiated CS experienced RECIST response<sup><a href="#ref-63">63</a></sup>. However, in a French multi-center, phase 2 trial of pembrolizumab with metronomic cyclophosphamide, 1 out of 50 patients with soft-tissue sarcoma (STS) experienced response, and 0 out of 2 subjects with extraskeletal CS responded<sup><a href="#ref-64">64</a></sup>. Additionally, the Alliance for Clinical Trials in Oncology conducted a randomized phase 2 trial of the anti-PD-1 antibody nivolumab alone or in combination with the anti-CTLA4 antibody ipilimumab in patients with STS or bone sarcoma<sup><a href="#ref-65">65</a></sup>. The overall response rate was 5% with nivolumab monotherapy and 16% with the combination. However, bone sarcomas accounted for only 12% of the monotherapy cohort and 10% of the combination therapy cohort. Furthermore, only 1 dedifferentiated CS was in each cohort, and neither experienced response. Novel checkpoint blockade combinations will likely be required to advance immunotherapy in CS.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39988e755>Summary</h2><p class="" id=d39988e758>Advances in CS genetics, epigenetics, and biology have significantly informed this disease’s underlying oncogenesis. However, this has yet to translate into substantial advancements in therapy. Sustained research will be needed in this rare and sometimes deadly cancer. Novel therapeutic breakthroughs will likely be a result in the not-too-distant future. It is probable that combination therapy targeting multiple pathways will be required to effectively treat advanced CS.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d39988e1 class=n-a></a><h2 class=main-title id=d40211>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d39988e765 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d40414>References</h2><div class="section ref-list"><a name=d39988e765 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d39988e772 class=n-a></a>Hogendoorn PCW, Bovée JV, Nielsen GP: Chondrosarcoma (grades I-III), including primary and secondary variants and periosteal chondrosarcoma. In: Fletcher CD, Bridge JA, Hogendoorn PC, <i>et al</i>. editors. World Health Organization classification of tumours. <i>Pathology and genetics of tumours of soft tissue and bone</i>. 4<sup>th</sup> edition. Lyon: IARC Press; 2013; 264–268. </span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d39988e790 class=n-a></a>van Oosterwijk JG, Anninga JK, Gelderblom H, <i> et al.</i>: Update on targets and novel treatment options for high-grade osteosarcoma and chondrosarcoma. <i>Hematol Oncol Clin North Am.</i> 2013; <b>27</b>(5): 1021–48. <a target=xrefwindow id=d39988e801 href="http://www.ncbi.nlm.nih.gov/pubmed/24093174">PubMed Abstract </a> | <a target=xrefwindow id=d39988e804 href="https://doi.org/10.1016/j.hoc.2013.07.012">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d39988e813 class=n-a></a>Heck RK Jr, Peabody TD, Simon MA: Staging of primary malignancies of bone. <i>CA Cancer J Clin.</i> 2006; <b>56</b>(6): 366–75. <a target=xrefwindow id=d39988e821 href="http://www.ncbi.nlm.nih.gov/pubmed/17135693">PubMed Abstract </a> | <a target=xrefwindow id=d39988e824 href="https://doi.org/10.3322/canjclin.56.6.366">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d39988e833 class=n-a></a>Chow WA: Update on chondrosarcomas. <i>Curr Opin Oncol.</i> 2007; <b>19</b>(4): 371–6. <a target=xrefwindow id=d39988e841 href="http://www.ncbi.nlm.nih.gov/pubmed/17545802">PubMed Abstract </a> | <a target=xrefwindow id=d39988e844 href="https://doi.org/10.1097/CCO.0b013e32812143d9">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d39988e853 class=n-a></a>Shmookler B, Bickels J, Jelinek J, <i> et al.</i>: Bone and soft-tissue sarcomas: epidemiology, radiology, pathology and fundamentals of surgical treatment. In: Malawer M, Sugarbaker PH editors. <i>Musculoskeletal cancer surgery: treatment of sarcomas and allied diseases</i>. Boston: Kluwer Academic Publishers, 2001; 247–251. <a target=xrefwindow id=d39988e861 href="http://sarcoma.org/publications/mcs/ch1.pdf">Reference Source</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d39988e871 class=n-a></a>Italiano A, Mir O, Cioffi A, <i> et al.</i>: Advanced chondrosarcomas: role of chemotherapy and survival. <i>Ann Oncol.</i> 2013; <b>24</b>(11): 2916–22. <a target=xrefwindow id=d39988e882 href="http://www.ncbi.nlm.nih.gov/pubmed/24099780">PubMed Abstract </a> | <a target=xrefwindow id=d39988e885 href="https://doi.org/10.1093/annonc/mdt374">Publisher Full Text </a> | <a target=xrefwindow id=d39988e889 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3811906">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d39988e898 class=n-a></a>Provenzano S, Hindi N, Morosi C, <i> et al.</i>: Response of conventional chondrosarcoma to gemcitabine alone: a case report. <i>Clin Sarcoma Res.</i> 2015; <b>5</b>: 9. <a target=xrefwindow id=d39988e909 href="http://www.ncbi.nlm.nih.gov/pubmed/25793102">PubMed Abstract </a> | <a target=xrefwindow id=d39988e912 href="https://doi.org/10.1186/s13569-015-0025-z">Publisher Full Text </a> | <a target=xrefwindow id=d39988e916 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4365557">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d39988e925 class=n-a></a>Wang L, Motoi T, Khanin R, <i> et al.</i>: Identification of a novel, recurrent <i>HEY1-NCOA2</i> fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. <i>Genes Chromosomes Cancer.</i> 2012; <b>51</b>(2): 127–39. <a target=xrefwindow id=d39988e939 href="http://www.ncbi.nlm.nih.gov/pubmed/22034177">PubMed Abstract </a> | <a target=xrefwindow id=d39988e943 href="https://doi.org/10.1002/gcc.20937">Publisher Full Text </a> | <a target=xrefwindow id=d39988e946 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3235801">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d39988e955 class=n-a></a>Frezza AM, Cesari M, Baumhoer D, <i> et al.</i>: Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study. <i>Eur J Cancer.</i> 2015; <b>51</b>(3): 374–81. <a target=xrefwindow id=d39988e966 href="http://www.ncbi.nlm.nih.gov/pubmed/25529371">PubMed Abstract </a> | <a target=xrefwindow id=d39988e969 href="https://doi.org/10.1016/j.ejca.2014.11.007">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d39988e978 class=n-a></a>McCarthy EF, Hogendoorn PCW: Clear cell chondrosarcoma. In: Fletcher CD, Bridge JA, Hogendoorn PC, <i>et al</i>. editors. World Health Organization classification of tumours. <i>Pathology and genetics of tumours of soft tissue and bone</i>. 4<sup>th</sup> edition. Lyon: IARC Press; 2013; 273–274. </span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d39988e996 class=n-a></a>Drilon AD, Popat S, Bhuchar G, <i> et al.</i>: Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy. <i>Cancer.</i> 2008; <b>113</b>(12): 3364–71. <a target=xrefwindow id=d39988e1007 href="http://www.ncbi.nlm.nih.gov/pubmed/18951519">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1010 href="https://doi.org/10.1002/cncr.23978">Publisher Full Text </a> | <a target=xrefwindow id=d39988e1014 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2779719">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d39988e1024 class=n-a></a>Clark J, Benjamin H, Gill S, <i> et al.</i>: Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. <i>Oncogene.</i> 1996; <b>12</b>(2): 229–35. <a target=xrefwindow id=d39988e1035 href="http://www.ncbi.nlm.nih.gov/pubmed/8570200">PubMed Abstract </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d39988e1044 class=n-a></a>Sjögren H, Meis-Kindblom J, Kindblom LG, <i> et al.</i>: Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma. <i>Cancer Res.</i> 1999; <b>59</b>(20): 5064–7. <a target=xrefwindow id=d39988e1055 href="http://www.ncbi.nlm.nih.gov/pubmed/10537274">PubMed Abstract </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d39988e1064 class=n-a></a>Hisaoka M, Ishida T, Imamura T, <i> et al.</i>: <i>TFG</i> is a novel fusion partner of <i>NOR1</i> in extraskeletal myxoid chondrosarcoma. <i>Genes Chromosomes Cancer.</i> 2004; <b>40</b>(4): 325–8. <a target=xrefwindow id=d39988e1082 href="http://www.ncbi.nlm.nih.gov/pubmed/15188455">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1085 href="https://doi.org/10.1002/gcc.20044">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d39988e1094 class=n-a></a>Samuel AM, Costa J, Lindskog DM: Genetic alterations in chondrosarcomas - keys to targeted therapies? <i>Cell Oncol (Dordr).</i> 2014; <b>37</b>(2): 95–105. <a target=xrefwindow id=d39988e1102 href="http://www.ncbi.nlm.nih.gov/pubmed/24458248">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1105 href="https://doi.org/10.1007/s13402-014-0166-8">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d39988e1114 class=n-a></a>Bovée JV, Heymann D, Wuyts W: Osteochondroma. In: Fletcher CD, Bridge JA, Hogendoorn PC, <i>et al</i>. editors. World Health Organization classification of tumours. <i>Pathology and genetics of tumours of soft tissue and bone</i>. 4<sup>th</sup> edition. Lyon: IARC Press; 2013; 250–251. </span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d39988e1132 class=n-a></a>Wicklund CL, Pauli RM, Johnston D, <i> et al.</i>: Natural history study of hereditary multiple exostoses. <i>Am J Med Genet.</i> 1995; <b>55</b>(1): 43–6. <a target=xrefwindow id=d39988e1143 href="http://www.ncbi.nlm.nih.gov/pubmed/7702095">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1146 href="https://doi.org/10.1002/ajmg.1320550113">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d39988e1156 class=n-a></a>Ahn J, Lüdecke HJ, Lindow S, <i> et al.</i>: Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (<i>EXT1</i>). <i>Nat Genet.</i> 1995; <b>11</b>(2): 137–43. <a target=xrefwindow id=d39988e1170 href="http://www.ncbi.nlm.nih.gov/pubmed/7550340">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1174 href="https://doi.org/10.1038/ng1095-137">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d39988e1183 class=n-a></a>Stickens D, Clines G, Burbee D, <i> et al.</i>: The <i>EXT2</i> multiple exostoses gene defines a family of putative tumour suppressor genes. <i>Nat Genet.</i> 1996; <b>14</b>(1): 25–32. <a target=xrefwindow id=d39988e1197 href="http://www.ncbi.nlm.nih.gov/pubmed/8782816">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1201 href="https://doi.org/10.1038/ng0996-25">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d39988e1210 class=n-a></a>de Andrea CE, Reijnders CM, Kroon HM, <i> et al.</i>: Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional <i>EXT</i>. <i>Oncogene.</i> 2012; <b>31</b>(9): 1095–104. <a target=xrefwindow id=d39988e1224 href="http://www.ncbi.nlm.nih.gov/pubmed/21804604">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1228 href="https://doi.org/10.1038/onc.2011.311">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d39988e1237 class=n-a></a>Amary MF, Damato S, Halai D, <i> et al.</i>: Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of <i>IDH1 and IDH2</i>. <i>Nat Genet.</i> 2011; <b>43</b>(12): 1262–5. <a target=xrefwindow id=d39988e1251 href="http://www.ncbi.nlm.nih.gov/pubmed/22057236">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1255 href="https://doi.org/10.1038/ng.994">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d39988e1264 class=n-a></a>Bovée JVMG, Alman BA: Endhondromatosis: Ollier disease and Maffucci syndrome. In: Fletcher CD, Bridge JA, Hogendoorn PCW, <i>et al</i>. editors. World Health Organization classification of tumours. <i>Pathology and genetics of tumours of soft tissue and bone</i>. 4<sup>th</sup> edition. Lyon: IARC Press; 2013; 376–378. </span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d39988e1282 class=n-a></a>Amary MF, Bacsi K, Maggiani F, <i> et al.</i>: <i>IDH1</i> and <i>IDH2</i> mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. <i>J Pathol.</i> 2011; <b>224</b>(3): 334–43. <a target=xrefwindow id=d39988e1300 href="http://www.ncbi.nlm.nih.gov/pubmed/21598255">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1303 href="https://doi.org/10.1002/path.2913">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d39988e1313 class=n-a></a>Schaap FG, French PJ, Bovée JV: Mutations in the isocitrate dehydrogenase genes <i>IDH1</i> and <i>IDH2</i> in tumors. <i>Adv Anat Pathol.</i> 2013; <b>20</b>(1): 32–8. <a target=xrefwindow id=d39988e1327 href="http://www.ncbi.nlm.nih.gov/pubmed/23232569">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1331 href="https://doi.org/10.1097/PAP.0b013e31827b654d">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1168419"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39988e1340 class=n-a></a>Dang L, White DW, Gross S, <i> et al.</i>: Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. <i>Nature.</i> 2009; <b>462</b>(7274): 739–44. <a target=xrefwindow id=d39988e1351 href="http://www.ncbi.nlm.nih.gov/pubmed/19935646">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1354 href="https://doi.org/10.1038/nature08617">Publisher Full Text </a> | <a target=xrefwindow id=d39988e1358 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2818760">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1168419">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731797843"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39988e1371 class=n-a></a>Urban DJ, Martinez NJ, Davis MI, <i> et al.</i>: Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays. <i>Sci Rep.</i> 2017; <b>7</b>(1): 12758. <a target=xrefwindow id=d39988e1382 href="http://www.ncbi.nlm.nih.gov/pubmed/28986582">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1385 href="https://doi.org/10.1038/s41598-017-12630-x">Publisher Full Text </a> | <a target=xrefwindow id=d39988e1389 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5630632">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731797843">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718064196"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39988e1402 class=n-a></a>Tarpey PS, Behjati S, Cooke SL, <i> et al.</i>: Frequent mutation of the major cartilage collagen gene <i>COL2A1</i> in chondrosarcoma. <i>Nat Genet.</i> 2013; <b>45</b>(8): 923–6. <a target=xrefwindow id=d39988e1416 href="http://www.ncbi.nlm.nih.gov/pubmed/23770606">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1420 href="https://doi.org/10.1038/ng.2668">Publisher Full Text </a> | <a target=xrefwindow id=d39988e1423 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3743157">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718064196">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727399380"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39988e1436 class=n-a></a>Wu F, Zhang Y, Sun B, <i> et al.</i>: Hedgehog Signaling: From Basic Biology to Cancer Therapy. <i>Cell Chem Biol.</i> 2017; <b>24</b>(3): 252–80. <a target=xrefwindow id=d39988e1447 href="http://www.ncbi.nlm.nih.gov/pubmed/28286127">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1450 href="https://doi.org/10.1016/j.chembiol.2017.02.010">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727399380">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d39988e1463 class=n-a></a>Xiang W, Jiang T, Guo F, <i> et al.</i>: Hedgehog pathway inhibitor-4 suppresses malignant properties of chondrosarcoma cells by disturbing tumor ciliogenesis. <i>Oncol Rep.</i> 2014; <b>32</b>(4): 1622–30. <a target=xrefwindow id=d39988e1474 href="http://www.ncbi.nlm.nih.gov/pubmed/25110171">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1477 href="https://doi.org/10.3892/or.2014.3372">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d39988e1487 class=n-a></a>Campbell VT, Nadesan P, Ali SA, <i> et al.</i>: Hedgehog pathway inhibition in chondrosarcoma using the smoothened inhibitor IPI-926 directly inhibits sarcoma cell growth. <i>Mol Cancer Ther.</i> 2014; <b>13</b>(5): 1259–69. <a target=xrefwindow id=d39988e1498 href="http://www.ncbi.nlm.nih.gov/pubmed/24634412">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1501 href="https://doi.org/10.1158/1535-7163.MCT-13-0731">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d39988e1510 class=n-a></a>Wagner AJ, Hohenberger P, Okuno S, <i> et al.</i>: Results from a phase 2 randomized, placebo-controlled, double blind study of the hedgehog pathway antagonist IPI-926 in patients with advanced chondrosarcoma. New York, New York, USA: Presented at the Connective Tissue Oncology Society Annual Meeting; 2013. </span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d39988e1522 class=n-a></a>Italiano A, Le Cesne A, Bellera C, <i> et al.</i>: GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study. <i>Ann Oncol.</i> 2013; <b>24</b>(11): 2922–6. <a target=xrefwindow id=d39988e1533 href="http://www.ncbi.nlm.nih.gov/pubmed/24170610">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1536 href="https://doi.org/10.1093/annonc/mdt391">Publisher Full Text </a> | <a target=xrefwindow id=d39988e1540 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3811907">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d39988e1549 class=n-a></a>Schrage YM, Lam S, Jochemsen AG, <i> et al.</i>: Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth <i>in vitro</i>. <i>J Cell Mol Med.</i> 2009; <b>13</b>(9A): 2843–52. <a target=xrefwindow id=d39988e1563 href="http://www.ncbi.nlm.nih.gov/pubmed/18624751">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1567 href="https://doi.org/10.1111/j.1582-4934.2008.00406.x">Publisher Full Text </a> | <a target=xrefwindow id=d39988e1570 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4498940">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d39988e1579 class=n-a></a>Röpke M, Boltze C, Meyer B, <i> et al.</i>: Rb-loss is associated with high malignancy in chondrosarcoma. <i>Oncol Rep.</i> 2006; <b>15</b>(1): 89–95. <a target=xrefwindow id=d39988e1590 href="http://www.ncbi.nlm.nih.gov/pubmed/16328039">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1593 href="https://doi.org/10.3892/or.15.1.89">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d39988e1602 class=n-a></a>Blasenbreu S, Baretton GB, Bender C, <i> et al.</i>: [TP53 gene aberrations in chondromatous neoplasms: correlation with immunohistochemical p53 accumulation and MDM2 expression]. <i>Verh Dtsch Ges Pathol.</i> 1998; <b>82</b>: 284–9. <a target=xrefwindow id=d39988e1613 href="http://www.ncbi.nlm.nih.gov/pubmed/10095448">PubMed Abstract </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d39988e1623 class=n-a></a>Ray-Coquard I, Blay JY, Italiano A, <i> et al.</i>: Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with <i>MDM2</i>-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study. <i>Lancet Oncol.</i> 2012; <b>13</b>(11): 1133–40. <a target=xrefwindow id=d39988e1637 href="http://www.ncbi.nlm.nih.gov/pubmed/23084521">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1641 href="https://doi.org/10.1016/S1470-2045(12)70474-6">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d39988e1650 class=n-a></a>Lin C, Meitner PA, Terek RM: PTEN mutation is rare in chondrosarcoma. <i>Diagn Mol Pathol.</i> 2002; <b>11</b>(1): 22–6. <a target=xrefwindow id=d39988e1658 href="http://www.ncbi.nlm.nih.gov/pubmed/11854598">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1661 href="https://doi.org/10.1097/00019606-200203000-00005">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d39988e1670 class=n-a></a>Zhang YX, van Oosterwijk JG, Sicinska E, <i> et al.</i>: Functional profiling of receptor tyrosine kinases and downstream signaling in human chondrosarcomas identifies pathways for rational targeted therapy. <i>Clin Cancer Res.</i> 2013; <b>19</b>(14): 3796–807. <a target=xrefwindow id=d39988e1681 href="http://www.ncbi.nlm.nih.gov/pubmed/23714727">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1684 href="https://doi.org/10.1158/1078-0432.CCR-12-3647">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d39988e1693 class=n-a></a>Gibbons JJ, Abraham RT, Yu K: Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth. <i>Semin Oncol.</i> 2009; <b>36 Suppl 3</b>: S3–S17. <a target=xrefwindow id=d39988e1701 href="http://www.ncbi.nlm.nih.gov/pubmed/19963098">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1704 href="https://doi.org/10.1053/j.seminoncol.2009.10.011">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d39988e1713 class=n-a></a>Bernstein-Molho R, Kollender Y, Issakov J, <i> et al.</i>: Clinical activity of mTOR inhibition in combination with cyclophosphamide in the treatment of recurrent unresectable chondrosarcomas. <i>Cancer Chemother Pharmacol.</i> 2012; <b>70</b>(6): 855–60. <a target=xrefwindow id=d39988e1724 href="http://www.ncbi.nlm.nih.gov/pubmed/23053256">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1727 href="https://doi.org/10.1007/s00280-012-1968-x">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d39988e1736 class=n-a></a>Fromm B, Billipp T, Peck LE, <i> et al.</i>: A Uniform System for the Annotation of Vertebrate microRNA Genes and the Evolution of the Human microRNAome. <i>Annu Rev Genet.</i> 2015; <b>49</b>: 213–42. <a target=xrefwindow id=d39988e1747 href="http://www.ncbi.nlm.nih.gov/pubmed/26473382">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1750 href="https://doi.org/10.1146/annurev-genet-120213-092023">Publisher Full Text </a> | <a target=xrefwindow id=d39988e1754 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4743252">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d39988e1764 class=n-a></a>Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. <i>Cell.</i> 2005; <b>120</b>(1): 15–20. <a target=xrefwindow id=d39988e1772 href="http://www.ncbi.nlm.nih.gov/pubmed/15652477">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1775 href="https://doi.org/10.1016/j.cell.2004.12.035">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/14002958"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39988e1784 class=n-a></a>Martinez-Sanchez A, Dudek KA, Murphy CL: Regulation of human chondrocyte function through direct inhibition of cartilage master regulator SOX9 by microRNA-145 (miRNA-145). <i>J Biol Chem.</i> 2012; <b>287</b>(2): 916–24. <a target=xrefwindow id=d39988e1792 href="http://www.ncbi.nlm.nih.gov/pubmed/22102413">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1795 href="https://doi.org/10.1074/jbc.M111.302430">Publisher Full Text </a> | <a target=xrefwindow id=d39988e1798 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3256897">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/14002958">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d39988e1811 class=n-a></a>Zhu Z, Wang CP, Zhang YF, <i> et al.</i>: MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR. <i>Asian Pac J Cancer Prev.</i> 2014; <b>15</b>(2): 917–23. <a target=xrefwindow id=d39988e1822 href="http://www.ncbi.nlm.nih.gov/pubmed/24568519">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1825 href="https://doi.org/10.7314/APJCP.2014.15.2.917">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728852739"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39988e1834 class=n-a></a>Lu N, Lin T, Wang L, <i> et al.</i>: Association of SOX<sub>4</sub> regulated by tumor suppressor miR-30a with poor prognosis in low-grade chondrosarcoma. <i>Tumour Biol.</i> 2015; <b>36</b>(5): 3843–52. <a target=xrefwindow id=d39988e1848 href="http://www.ncbi.nlm.nih.gov/pubmed/25572678">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1852 href="https://doi.org/10.1007/s13277-014-3026-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728852739">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725519221"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39988e1865 class=n-a></a>Sun X, Charbonneau C, Wei L, <i> et al.</i>: miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis. <i>Mol Cancer Res.</i> 2015; <b>13</b>(9): 1347–57. <a target=xrefwindow id=d39988e1876 href="http://www.ncbi.nlm.nih.gov/pubmed/26013170">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1879 href="https://doi.org/10.1158/1541-7786.MCR-14-0697">Publisher Full Text </a> | <a target=xrefwindow id=d39988e1883 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4573256">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725519221">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d39988e1896 class=n-a></a>Asp J, Sangiorgi L, Inerot SE, <i> et al.</i>: Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues. <i>Int J Cancer.</i> 2000; <b>85</b>(6): 782–6. <a target=xrefwindow id=d39988e1907 href="http://www.ncbi.nlm.nih.gov/pubmed/10709095">PubMed Abstract </a> | <a target="xrefwindow" id="d39988e1910" href="https://doi.org/10.1002/(SICI)1097-0215(20000315)85:6<782::AID-IJC7&gt;3.0.CO;2-O">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d39988e1920 class=n-a></a>Jin Z, Han YX, Han XR: Loss of RUNX3 expression may contribute to poor prognosis in patients with chondrosarcoma. <i>J Mol Histol.</i> 2013; <b>44</b>(6): 645–52. <a target=xrefwindow id=d39988e1928 href="http://www.ncbi.nlm.nih.gov/pubmed/23666463">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1931 href="https://doi.org/10.1007/s10735-013-9511-x">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727842415"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39988e1940 class=n-a></a>Cleven AHG, Suijker J, Agrogiannis G, <i> et al.</i>: <i>IDH1</i> or -<i>2</i> mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas. <i>Clin Sarcoma Res.</i> 2017; <b>7</b>: 8. <a target=xrefwindow id=d39988e1958 href="http://www.ncbi.nlm.nih.gov/pubmed/28484589">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1961 href="https://doi.org/10.1186/s13569-017-0074-6">Publisher Full Text </a> | <a target=xrefwindow id=d39988e1964 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5418698">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727842415">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d39988e1977 class=n-a></a>Bui C, Ouzzine M, Talhaoui I, <i> et al.</i>: Epigenetics: methylation-associated repression of heparan sulfate 3-<i>O</i>-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells. <i>FASEB J.</i> 2010; <b>24</b>(2): 436–50. <a target=xrefwindow id=d39988e1991 href="http://www.ncbi.nlm.nih.gov/pubmed/19812376">PubMed Abstract </a> | <a target=xrefwindow id=d39988e1995 href="https://doi.org/10.1096/fj.09-136291">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d39988e2004 class=n-a></a>Hamm CA, Xie H, Costa FF, <i> et al.</i>: Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2'-deoxycytidine results in increased tumorigenicity. <i>PLoS One.</i> 2009; <b>4</b>(12): e8340. <a target=xrefwindow id=d39988e2015 href="http://www.ncbi.nlm.nih.gov/pubmed/20019818">PubMed Abstract </a> | <a target=xrefwindow id=d39988e2018 href="https://doi.org/10.1371/journal.pone.0008340">Publisher Full Text </a> | <a target=xrefwindow id=d39988e2022 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2790612">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726786878"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39988e2031 class=n-a></a>Hamidi H, Pietilä M, Ivaska J: The complexity of integrins in cancer and new scopes for therapeutic targeting. <i>Br J Cancer.</i> 2016; <b>115</b>(9): 1017–23. <a target=xrefwindow id=d39988e2039 href="http://www.ncbi.nlm.nih.gov/pubmed/27685444">PubMed Abstract </a> | <a target=xrefwindow id=d39988e2042 href="https://doi.org/10.1038/bjc.2016.312">Publisher Full Text </a> | <a target=xrefwindow id=d39988e2045 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5117799">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726786878">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d39988e2058 class=n-a></a>Chen JC, Fong YC, Tang CH: Novel strategies for the treatment of chondrosarcomas: targeting integrins. <i>Biomed Res Int.</i> 2013; <b>2013</b>: 396839. <a target=xrefwindow id=d39988e2066 href="http://www.ncbi.nlm.nih.gov/pubmed/24490159">PubMed Abstract </a> | <a target=xrefwindow id=d39988e2069 href="https://doi.org/10.1155/2013/396839">Publisher Full Text </a> | <a target=xrefwindow id=d39988e2072 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3893802">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d39988e2082 class=n-a></a>Wu CM, Li TM, Hsu SF, <i> et al.</i>: IGF-I enhances α5β1 integrin expression and cell motility in human chondrosarcoma cells. <i>J Cell Physiol.</i> 2011; <b>226</b>(12): 3270–7. <a target=xrefwindow id=d39988e2093 href="http://www.ncbi.nlm.nih.gov/pubmed/21344385">PubMed Abstract </a> | <a target=xrefwindow id=d39988e2096 href="https://doi.org/10.1002/jcp.22688">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d39988e2105 class=n-a></a>Lai TH, Fong YC, Fu WM, <i> et al.</i>: Stromal cell-derived factor-1 increase alphavbeta3 integrin expression and invasion in human chondrosarcoma cells. <i>J Cell Physiol.</i> 2009; <b>218</b>(2): 334–42. <a target=xrefwindow id=d39988e2116 href="http://www.ncbi.nlm.nih.gov/pubmed/18814143">PubMed Abstract </a> | <a target=xrefwindow id=d39988e2119 href="https://doi.org/10.1002/jcp.21601">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d39988e2128 class=n-a></a>Stupp R, Hegi ME, Gorlia T, <i> et al.</i>: Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. <i>Lancet Oncol.</i> 2014; <b>15</b>(10): 1100–8. <a target=xrefwindow id=d39988e2142 href="http://www.ncbi.nlm.nih.gov/pubmed/25163906">PubMed Abstract </a> | <a target=xrefwindow id=d39988e2146 href="https://doi.org/10.1016/S1470-2045(14)70379-1">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d39988e2155 class=n-a></a>Élez E, Kocáková I, Höhler T, <i> et al.</i>: Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with <i>KRAS</i> wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial. <i>Ann Oncol.</i> 2015; <b>26</b>(1): 132–40. <a target=xrefwindow id=d39988e2169 href="http://www.ncbi.nlm.nih.gov/pubmed/25319061">PubMed Abstract </a> | <a target=xrefwindow id=d39988e2173 href="https://doi.org/10.1093/annonc/mdu474">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d39988e2182 class=n-a></a>Lin C, McGough R, Aswad B, <i> et al.</i>: Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes. <i>J Orthop Res.</i> 2004; <b>22</b>(6): 1175–81. <a target=xrefwindow id=d39988e2193 href="http://www.ncbi.nlm.nih.gov/pubmed/15475194">PubMed Abstract </a> | <a target=xrefwindow id=d39988e2196 href="https://doi.org/10.1016/j.orthres.2004.03.002">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d39988e2205 class=n-a></a>Kubo T, Sugita T, Shimose S, <i> et al.</i>: Expression of hypoxia-inducible factor-1alpha and its relationship to tumour angiogenesis and cell proliferation in cartilage tumours. <i>J Bone Joint Surg Br.</i> 2008; <b>90</b>(3): 364–70. <a target=xrefwindow id=d39988e2216 href="http://www.ncbi.nlm.nih.gov/pubmed/18310762">PubMed Abstract </a> | <a target=xrefwindow id=d39988e2219 href="https://doi.org/10.1302/0301-620X.90B3.19806">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d39988e2229 class=n-a></a>Ayala G, Liu C, Nicosia R, <i> et al.</i>: Microvasculature and VEGF expression in cartilaginous tumors. <i>Hum Pathol.</i> 2000; <b>31</b>(3): 341–6. <a target=xrefwindow id=d39988e2240 href="http://www.ncbi.nlm.nih.gov/pubmed/10746677">PubMed Abstract </a> | <a target=xrefwindow id=d39988e2243 href="https://doi.org/10.1016/S0046-8177(00)80248-8">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727738129"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39988e2252 class=n-a></a>Carbone DP, Reck M, Paz-Ares L, <i> et al.</i>: First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer. <i>N Engl J Med.</i> 2017; <b>376</b>(25): 2415–26. <a target=xrefwindow id=d39988e2263 href="http://www.ncbi.nlm.nih.gov/pubmed/28636851">PubMed Abstract </a> | <a target=xrefwindow id=d39988e2266 href="https://doi.org/10.1056/NEJMoa1613493">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727738129">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727523749"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39988e2279 class=n-a></a>Chalmers ZR, Connelly CF, Fabrizio D, <i> et al.</i>: Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. <i>Genome Med.</i> 2017; <b>9</b>(1): 34. <a target=xrefwindow id=d39988e2290 href="http://www.ncbi.nlm.nih.gov/pubmed/28420421">PubMed Abstract </a> | <a target=xrefwindow id=d39988e2293 href="https://doi.org/10.1186/s13073-017-0424-2">Publisher Full Text </a> | <a target=xrefwindow id=d39988e2297 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5395719 ">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727523749">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731932303"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39988e2310 class=n-a></a>Tawbi HA, Burgess M, Bolejack V, <i> et al.</i>: Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. <i>Lancet Oncol.</i> 2017; <b>18</b>(11): 1493–501. <a target=xrefwindow id=d39988e2321 href="http://www.ncbi.nlm.nih.gov/pubmed/28988646">PubMed Abstract </a> | <a target=xrefwindow id=d39988e2324 href="https://doi.org/10.1016/S1470-2045(17)30624-1">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731932303">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727784209"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39988e2337 class=n-a></a>Toulmonde M, Penel N, Adam J, <i> et al.</i>: Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial. <i>JAMA Oncol.</i> 2018; <b>4</b>(1): 93–7. <a target=xrefwindow id=d39988e2348 href="http://www.ncbi.nlm.nih.gov/pubmed/28662235">PubMed Abstract </a> | <a target=xrefwindow id=d39988e2351 href="https://doi.org/10.1001/jamaoncol.2017.1617">Publisher Full Text </a> | <a target=xrefwindow id=d39988e2355 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5833654">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727784209">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732571654"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39988e2368 class=n-a></a>D'Angelo SP, Mahoney MR, van Tine BA, <i> et al.</i>: Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials. <i>Lancet Oncol.</i> 2018; <b>19</b>(3): 416–26. <a target=xrefwindow id=d39988e2379 href="http://www.ncbi.nlm.nih.gov/pubmed/29370992">PubMed Abstract </a> | <a target=xrefwindow id=d39988e2382 href="https://doi.org/10.1016/S1470-2045(18)30006-8">Publisher Full Text </a> | <a target=xrefwindow id=d39988e2386 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6126546">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732571654">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 20 Nov 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1826&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1826&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Medical Oncology &amp; Therapeutics Research, City of Hope, 1500 E. Duarte Rd, Duarte, CA, 91010, USA<br/> <p> <div class=margin-bottom> Warren A Chow <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Resources, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1826/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 20 Nov 2018, 7:1826 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.15953.1">https://doi.org/10.12688/f1000research.15953.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Chow WA. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=17424 data-id=15953 data-downloads="" data-views="" data-scholar="10.12688/f1000research.15953.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1826/v1/pdf?article_uuid=c8cf8801-6c95-417a-b343-e6003e1bf932" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.15953.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Chow WA. Chondrosarcoma: biology, genetics, and epigenetics [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1826 (<a href="https://doi.org/10.12688/f1000research.15953.1" target=_blank>https://doi.org/10.12688/f1000research.15953.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=15953 id=mobile-track-article-signin-15953 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/15953?target=/articles/7-1826"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17424 /> <input name=articleId type=hidden value=15953 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Robin L Jones</strong>, Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Shreyaskumar Patel</strong>, Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 20 Nov 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1826&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1826&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=41732-40644></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=18252-40642></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1826/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>20 Nov 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Robin L Jones</strong>, Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Shreyaskumar Patel</strong>, Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1826&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1826/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Chondrosarcoma: biology, genetics, and epigenetics".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1826/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1826/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1826/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Chow WA');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1826/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1826",
            templates : {
                twitter : "Chondrosarcoma: biology, genetics, and epigenetics. Chow WA, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1826/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Chondrosarcoma: biology, genetics, and epigenetics", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Chondrosarcoma: biology, genetics, and epigenetics", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/15953/17424")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "17424");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "40642": 0,
                           "40643": 0,
                           "40644": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "e4121710-8a8b-45d9-8ccc-2bc789557663";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1826.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1826.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1826.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1826.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1826.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>